# The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy

> **NCT01369641** · NA · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 1 (actual)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** Insertion of Pressure Equalization (PE) Tubes
- **DRUG:** Sodium Thiosulfate (STS)
- **OTHER:** Saline (Placebo)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01369641
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08-24
- **Primary completion:** 2013-03-10
- **Final completion:** 2013-05-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01369641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01369641, "The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01369641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*